Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries
about
Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentChanges in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workersCurrent Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingRandomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.Incident HSV-2 infections are common among HIV-1-discordant couples.Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review.Herpes Simplex Virus Type 2 Seroprevalence among Different National Populations of Middle East and North African Males.
P2860
Q35207119-936BF869-2C4B-4D70-BDA8-4ABC118DE62AQ35209414-035F5D15-70D7-48A5-9AA7-2D7E0F5B7792Q35794339-2B28E075-9D86-43F0-80AA-18E5FB3943BFQ36076166-A3F2C474-A20B-4EBC-8937-0D8537AD324CQ36269081-742AC2B1-3370-450B-8BDB-8C119D812E5BQ36630996-3A82A312-BAF0-4000-AFE3-030ABC06892EQ36812845-27C628C1-3C9F-4841-B073-D25048460ABDQ36931777-F4B247FE-C79B-41D4-A4DC-C4FA4FEC7A48Q37145745-4B6FA4B1-CDE5-435E-8B2F-18F5C04BB3B1Q37212998-5A7C91FD-87AA-486F-AF1B-B937D6261D74Q37516826-CB84FAD4-1D16-4775-B502-A3999DCFFD49Q37635159-F498A6AF-9771-49A1-B469-A1186DF1CBC0Q38060100-3387F86E-7730-492F-A887-A76BD2EAABE6Q49711478-6CA50011-928B-4B52-ACBA-78BB6351D527
P2860
Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Performance of the Focus Herpe ...... ies in seven African countries
@ast
Performance of the Focus Herpe ...... ies in seven African countries
@en
Performance of the Focus Herpe ...... ies in seven African countries
@nl
type
label
Performance of the Focus Herpe ...... ies in seven African countries
@ast
Performance of the Focus Herpe ...... ies in seven African countries
@en
Performance of the Focus Herpe ...... ies in seven African countries
@nl
prefLabel
Performance of the Focus Herpe ...... ies in seven African countries
@ast
Performance of the Focus Herpe ...... ies in seven African countries
@en
Performance of the Focus Herpe ...... ies in seven African countries
@nl
P2093
P2860
P50
P356
P1476
Performance of the Focus Herpe ...... ies in seven African countries
@en
P2093
Andrew Mujugira
Bellington Vwalika
Brigitte Homawoo
Guy De Bruyn
Jairam Lingappa
Jared M Baeten
Kenneth H Fife
Nelly Mugo
Partners in Prevention HSV/HIV Transmission Study Team
Renee Heffron
P2860
P304
P356
10.1136/STI.2010.047415
P50
P577
2011-02-09T00:00:00Z